Clinical Trial Results:
Insulina humana preprandial inhalada con el sistema AERx® iDMS frente a insulina aspart s.c. en diabetes tipo 2: ensayo de 52 semanas de duración, abierto, multicéntrico, aleatorizado seguido de un periodo de extensión de 52 semanas y una extensión de 12 semanas con re-aleatorización para investigar la seguridad y la eficacia.
Inhaled pre-prandial human insulin with the AERx® iDMS versus s.c. insulin aspart in type 2 diabetes;
Summary
|
|
EudraCT number |
2005-005378-58 |
Trial protocol |
ES DK GB DE IT |
Global completion date |
05 May 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Feb 2016
|
First version publication date |
06 Feb 2016
|
Other versions |
|
Summary report(s) |
Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.